e-Connect Logo
Issue:  July 2013 •  Archive  •  Subscribe •  Unsubscribe
In This Edition Featured Article Featured CE
•  Editor's Notebook
•  Counseling Pearls
•  Senior Care
•  Clinical Corner
•  Consult Your Pharmacist
•  Educational Spotlight
•  Quick Poll – Obesity
  Photo Croup: What It Is and How to Treat It
The sudden onset of a barking cough is the hallmark symptom.
  Photo Community-Acquired Bacterial Pneumonia: A Primer for Pharmacists
CABP is the most frequently occurring infectious disease in the U.S.
Advertisement Photo

NEW! Follow us on
Fb Logo  Tw Logo

Advertisement  
Photo

Editor's Notebook
Stressed Out?…You’re Not Alone!

For many pharmacists, stress is synonymous with the practice of pharmacy.
Counseling Pearls
Photo Management of Stable Chronic Obstructive Pulmonary Disease

COPD is currently the third leading cause of death in the United States and is a major cause of disability. The recently updated GOLD guidelines address the treatment of stable COPD.
Photo Update on the Management of Streptococcal Pharyngitis

Acute pharyngitis is a common infection that is typically managed in the outpatient setting. Group A streptococcus is the most common bacterial cause of what is generally referred to as strep throat.
Senior Care
Diffuse Interstitial Lung Disease

An increase in the use of pneumotoxic drugs to treat malignancies and cardiovascular diseases in the elderly contributes to an increased incidence of this disease.
 
Clinical Corner
Photo Conventional and Investigational Treatment Options for PAH

Pulmonary arterial hypertension is a chronic condition that carries a significant risk of morbidity and mortality. New and emerging therapies include medications with novel molecular targets and dosing mechanisms.
Photo Hospital-Acquired Anaphylaxis

Currently, there is limited literature on the prevalence, cause, and risk factors of anaphylaxis in a hospital setting. However, it has been found that certain medications, latex, food, and contrast media may increase a patient’s risk.
 
Consult Your Pharmacist
Recent OTC Developments in Asthma

Due to environmental concerns, inhalers with CFC propellants are no longer available.
 
Educational Spotlight
Strategies for the Prevention and Management of Nevi (Moles)

The presence of multiple moles is associated with an increased risk of melanoma.
Recognizing and Treating Tonsillitis

Penicillin is considered the gold standard of therapy for this common childhood condition.
The TB/HIV Syndemic: Prevention, Detection, and Treatment

The presence of untreated tuberculosis may hasten the course of HIV infection.
 
Newswire
Exercise Pill a Possibility
Jupiter, FL — Researchers at the Scripps Research Institute in Jupiter, Florida, are developing a drug that mimics the benefits of exercise with no actual workout required. According to a study published in Nature Medicine, obese mice were injected with a compound that increased production of the muscle protein REV-ERB, which is known to partially control circadian rhythms and internal biological clocks. These animals lost weight, improved their cholesterol levels, and expended 5% more energy compared to mice in the control group, even though they were not exercising more. While it is still unclear whether or not the drug can be safely used in humans, the fundamental goal is to help disabled people experience some of the health benefits of exercise, not aid those who want to avoid physical activity.
ACPE Certifies First International Pharmacy Program
Chicago, IL— The Accreditation Council for Pharmacy Education (ACPE) has granted the first international pharmacy degree program certification to King Saud University College of Pharmacy in Saudi Arabia. Both of the university’s professional degree programs (bachelor of pharmacy and doctor of pharmacy) were certified. Certification is distinct from accreditation and is only available to professional degree programs outside the United States. In January 2011, ACPE established the International Services Program to offer services to international stakeholders who seek guidance related to quality assurance and advancement of pharmacy education. ACPE President Robert S. Beardsley, PhD, stated that his organization is "pleased to reach this important milestone."
FDA Approves Nonhormonal Treatment for Hot Flashes
Bethesda, MD— The FDA has approved Brisdelle (paroxetine) to treat moderate-to-severe hot flashes (vasomotor symptoms) associated with menopause. Hot flashes are very common and occur in up to 75% of menopausal women. Brisdelle, which contains the selective serotonin reuptake inhibitor (SSRI) paroxetine, is currently the only nonhormonal treatment for hot flashes approved by the FDA. There are a variety of other FDA-approved drugs for this condition, but all include estrogen. Brisdelle contains 7.5 mg of paroxetine, while other medications, such as Paxil and Pexeva, use higher doses of paroxetine and are approved for treating conditions such as depression, obsessive-compulsive disorder, and anxiety. Like all SSRIs, a boxed warning about suicidality is included in the Brisdelle label.
To subscribe to e-Connect, send your name, address, and email address to us by clicking here. U.S. Pharmacist is a monthly journal dedicated to providing the nation's pharmacists with up-to-date, authoritative, peer-reviewed clinical articles relevant to contemporary pharmacy practice in a variety of settings, including community pharmacy, hospitals, managed care systems, ambulatory care clinics, home care organizations, long-term care facilities, industry and academia. The publication is also useful to pharmacy technicians, students, other health professionals and individuals interested in health management. Pharmacists licensed in the U.S. can earn Continuing Education credits through Postgraduate Healthcare Education, LLC, accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.